We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$7.54B
AUM Growth
+$509M
Cap. Flow
+$81.8M
Cap. Flow %
1.08%
Top 10 Hldgs %
15.04%
Holding
1,277
New
87
Increased
539
Reduced
599
Closed
49

Sector Composition

Rank Sector Weight
1 Technology 21.29%
2 Healthcare 13.85%
3 Financials 13.17%
4 Consumer Discretionary 10.27%
5 Industrials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TENB icon
1051
Tenable Holdings
TENB
$4.01B
$339K ﹤0.01%
6,150
+160
+3% +$8.28K
TRU icon
1052
TransUnion
TRU
$15.3B
$336K ﹤0.01%
2,833
-44
-2% -$5.04K
USPH icon
1053
US Physical Therapy
USPH
$1.22B
$336K ﹤0.01%
3,508
-51
-1% -$5.11K
MMI icon
1054
Marcus & Millichap
MMI
$1.19B
$331K ﹤0.01%
6,441
+1,094
+20% +$51K
ALEX
1055
DELISTED
Alexander & Baldwin
ALEX
$328K ﹤0.01%
13,082
+2,209
+20% +$53.4K
EPC icon
1056
Edgewell Personal Care
EPC
$1.31B
$325K ﹤0.01%
7,103
+790
+13% +$31.9K
LESL icon
1057
Leslie's
LESL
$11M
$324K ﹤0.01%
685
+93
+16% +$40.1K
ARNC
1058
DELISTED
Arconic Corporation
ARNC
$324K ﹤0.01%
9,824
+2,556
+35% +$79.1K
PBA icon
1059
Pembina Pipeline
PBA
$27.6B
$320K ﹤0.01%
10,546
-4,552
-30% -$145K
DTM icon
1060
DT Midstream
DTM
$13.4B
$317K ﹤0.01%
6,616
+671
+11% +$32.1K
SSTK icon
1061
Shutterstock
SSTK
$219M
$317K ﹤0.01%
2,859
+692
+32% +$80.5K
CHDN icon
1062
Churchill Downs
CHDN
$6.12B
$314K ﹤0.01%
2,606
+164
+7% +$19.5K
PRVA icon
1063
Privia Health
PRVA
$2.87B
$312K ﹤0.01%
+12,060
New +$301K
CLBK icon
1064
Columbia Financial
CLBK
$1.13B
$311K ﹤0.01%
14,893
+1,656
+13% +$32.1K
GDX icon
1065
VanEck Gold Miners ETF
GDX
$27.4B
$311K ﹤0.01%
9,695
-1,464
-13% -$46.7K
SHOO icon
1066
Steven Madden
SHOO
$3.55B
$311K ﹤0.01%
6,697
-2,421
-27% -$111K
AXON
1067
Axon Enterprise
AXON
$46.4B
$310K ﹤0.01%
1,977
+483
+32% +$81.1K
SPXC icon
1068
SPX Corp
SPXC
$10.8B
$306K ﹤0.01%
5,144
+357
+7% +$21.6K
XEL icon
1069
Xcel Energy
XEL
$48.8B
$306K ﹤0.01%
4,512
+308
+7% +$20.1K
CONE
1070
DELISTED
CyrusOne Inc Common Stock
CONE
$306K ﹤0.01%
3,414
-17,004
-83% -$1.44M
KMI icon
1071
Kinder Morgan
KMI
$68.7B
$305K ﹤0.01%
19,226
-1,010
-5% -$16.8K
RARE icon
1072
Ultragenyx Pharmaceutical
RARE
$2.55B
$304K ﹤0.01%
3,611
-92
-2% -$7.49K
SCHG icon
1073
Schwab US Large-Cap Growth ETF
SCHG
$62.9B
$303K ﹤0.01%
14,808
+2,336
+19% +$46.7K
PRCH icon
1074
Porch Group
PRCH
$1.8B
$300K ﹤0.01%
19,226
-189
-1% -$3.64K
CX icon
1075
Cemex
CX
$16.3B
$299K ﹤0.01%
44,143
+5,216
+13% +$34K

Similar funds

Oppenheimer Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Oppenheimer Asset Management held 1,277 positions worth $7.54B, up 7.2% from $7.03B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer Asset Management's Q4 2021 filing shows 87 new, 539 increased, 599 reduced and 49 closed positions. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 241,081 shares worth $14.8M. The largest sale was Autodesk, an estimated $9.15M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer Asset Management's largest Q4 2021 buy was Vanguard FTSE All-World ex-US ETF: 241,081 shares worth $14.8M.
  • Oppenheimer Asset Management added most to iShares Currency Hedged MSCI EAFE ETF in Q4 2021, an estimated $18.6M increase.
  • Oppenheimer Asset Management's biggest Q4 2021 reduction was Autodesk, cutting an estimated $9.15M.
  • Oppenheimer Asset Management fully exited iShares MSCI EAFE Growth ETF in Q4 2021, selling an estimated $7.45M.
  • Oppenheimer Asset Management's ten largest holdings make up 15% of its $7.54B portfolio in Q4 2021.
  • Oppenheimer Asset Management opened 87 new positions and closed 49 in Q4 2021.
  • Oppenheimer Asset Management's portfolio value rose 7.2% quarter-over-quarter to $7.54B.

Based on Oppenheimer Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.